Nontyphoidal Salmonellosis with Salmonella Bacteraemia in Infants Under 3 Months

Clinical scenario

This protocol addresses nontyphoidal salmonellosis with confirmed or suspected Salmonella bacteraemia in infants under 3 months of age — a population that requires prompt, structured management.

Key clinical considerations

Salmonella bacteraemia in this age group carries an increased risk for serious complications. Current guidance recommends that CSF analysis be performed in all infants under three months presenting with bacteraemia, to evaluate for disseminated disease.

Treatment approach (partial)

Management involves a defined course of intravenous antibiotic therapy. The specific agent selection, dosing, and duration are set out in the full structured protocol.

Full regimen details — drug choice, dose, frequency, and duration — are available in the protocol below.

Instant Access to Structured Evidence-Based Regimens

References

Salmonella bacteremia

Due to the increased risk for complications following bacteraemia, it is recommended a CSF analysis is performed in all infants under three (3) months.

10 days IV antibiotics; CSF for all

View source ↗